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Abstract 
 During the summer of 1955, mass arsenic poisoning of bottle-fed infants 
occurred in the western part of Japan due to contaminated milk powder, and more than 
100 died; some childhood victims were later found to suffer from neurological sequelae 
in adolescence. This unique incident enabled us to explore infancy as a critical period of 5 
arsenic exposure in regard to developmental neurotoxicity and its possible persistence 
through adulthood. The purpose of this work is to evaluate the association between 
developmental arsenic exposure and the neurological outcomes more than 50 years later. 
We conducted a retrospective cohort study during the period from April 2012 to 
February 2013 in two hospitals in Okayama Prefecture, Japan. The study sample 10 
consisted of 50 individuals: 27 known poisoning victims from Okayama Prefecture, and 
23 non-exposed local controls of similar age. In addition to neurological examination, 
we adapted a battery of neurophysiological and neuropsychological tests to identify the 
types of brain functions affected by early-life arsenic exposure. While limited 
abnormalities were found in the neurophysiological tests, neuropsychological deficits 15 
were observed. Except for Finger tapping, all test scores in the exposed group – 
Vocabulary and Block Design from Wechsler Adults Intelligent Scale III, Design 
memory subtest from Wide Range Assessment of Memory and Learning 2, and 
Grooved pegboard test – were substantially below those obtained by the unexposed. The 
exposed group showed average performance at least 1.2 standard deviations below the 20 
average for the controls. Exposed participants performed less well than controls, even 
after exclusion of subjects with recognized disabilities or those with a high level of 
education. Adults who had suffered arsenic poisoning during infancy revealed 
neuropsychological dysfunctions, even among those subjects not recognized as having 
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disabilities. Developmental neurotoxicity due to arsenic likely results in permanent 
changes in brain functions. 
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1. Introduction 
 Chronic exposure to inorganic arsenic via inhalation or drinking-water 
ingestion has been convincingly linked to lung, skin, and urinary bladder cancer [18]. In 
addition, arsenic is known to cause neurotoxicity [10], and recent studies suggest that 
early-life exposure to arsenic can cause developmental neurotoxicity [17,21,23]. 5 
However, most previous studies were cross-sectional [14,22,24-29,32] and only a few 
studies were longitudinal [3,4,20], thus leaving the relation of adverse effects to the 
timing of exposure uncertain. Therefore, little is known about the possible variation in 
susceptibility depending on age, i.e., the critical period of exposure. 
 During the summer of 1955, mass arsenic poisoning of bottle-fed infants 10 
occurred in the western part of Japan due to contaminated milk powder that resulted in 
an estimated arsenic concentration in the reconstituted milk of about 4-7 mg/L [1,5]. 
The contaminated milk was announced as the cause of the poisoning cases and was 
recalled on August 24th 1955. At that point, exposures had lasted for at least four 
months since the change in formulation of the milk powder in April 1955 [5]. 15 
Approximately 13,000 Japanese children were affected, and most cases occurred in the 
western part of the country where the factory was located [7]. Affected infants 
manifested skin pigmentation, diarrhea, and fever, and more than 100 died from acute 
poisoning [5]. Subsequent studies showed that adolescents exposed as infants to the 
contaminated milk powder had a lower IQ than the general population [12,33].  20 
This unique incident of arsenic exposure enables us to explore infancy as a 
critical period of arsenic exposure in regard to developmental neurotoxicity persisting 
through adulthood. Therefore, we aimed to evaluate the association between 
developmental arsenic exposure from contaminated milk powder and the neurological, 
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neurophysiological, and neuropsychological outcomes more than 50 years later. The 
overall purpose was to identify the types of brain functions primarily affected by 
early-life arsenic exposure.  
 
2. Methods 5 
2.1. Study setting 
 We conducted a retrospective cohort study during the period from April 2012 
to February 2013 at two hospitals (Okayama Kyoritsu Hospital and Mizushima Kyodo 
Hospital) in Okayama Prefecture, Japan. We targeted Okayama Prefecture because this 
Prefecture was the most severely affected area in the country [5]. We determined 10 
neurological, neurophysiological, and neuropsychological outcomes as well as 
demographic characteristics using questionnaires in connection with the participants’ 
regular health examinations. All examiners were blinded as to the participants’ exposure 
status. 
 15 
2.2. Study participants 
 The study sample consisted of 50 individuals who provided written, informed 
consent for participation in the study: 27 among known poisoned victims in Okayama 
Prefecture and 23 local, non-exposed controls. Among those invited, three exposed and 
three non-exposed individuals refused to participate in the study. The exposed 20 
participants were identified from a list of victims known to the Hikari Association to 
receive free health care at the two hospitals (n=15). The Hikari Association is a 
public-interest foundation dedicated to provide permanent relief for the victims of the 
contaminated milk powder. It supports victims through various efforts, such as benefits, 
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including living allowance, and regular health examinations for those who have 
disabilities or a relevant medical diagnosis. According to the Hikari Association, it 
supports regular health examinations for victims with disorders specific to arsenic 
poisoning, such as intellectual disability, mental disorder, or skin lesions.. Among the 
15 participants identified through the Association, 12 received benefits for their 5 
disorders, while three participants did not receive any, because they did not suffer from 
qualifying disorders. The list of exposed participants was supplemented by a list of 
victims who did not receive regular health examinations offered by the Hikari 
Association but who could be reached through the two local hospitals (n= 12); the 
hospitals offered health care to these victims regardless of their current health status. 10 
Thirteen exposed participants were born in 1954 and were at least five months old when 
the contamination started, while 14 were born in 1955 and would therefore have been 
exposed at a younger age before the official warning against the milk powder was 
issued in August of 1955. No information could be retrieved about the duration of 
breast-feeding. We recruited 23 non-exposed controls from the medical staff, including 15 
clerks, nurses, laboratory technicians, and one physician at the two hospitals, at ages 
similar to the exposed participants. None of them had been exposed to the contaminated 
milk powder during infancy. 
 
2.3. Neurological tests 20 
 One neurologist employed at each of the two hospitals conducted all clinical 
neurological examinations. They performed a screening-type neurological examination 
including mental status (e.g., level of consciousness, speech and language, memory, 
agnosia, and apraxia), cranial nerves, motor system (e.g., visual inspection, tone, and 
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strength), sensory system (e.g., touch, pain, vibration, and joint position sense), reflexes, 
coordination (e.g., finger-nose-finger), and gait. They also asked the participants about 
symptoms related to autonomic function (e.g., genitourinary retention, incontinence, 
constipation, and diarrhea) and checked for orthostatic hypotension. Based on these 
results, they provided summary scores with regard to mental, motor, sensory, and 5 
autonomic functions being normal or abnormal.  
 
2.4. Neurophysiological tests 
 All of the neurophysiological tests [Nerve conduction velocity (NCV), 
brainstem auditory evoked potentials (BAEPs), and visual evoked potentials (VEPs)] 10 
were conducted in the hospitals using standardized methods and the same 
instrumentation (Neuropack S1, Nihon Kohden). We calculated motor NCV of the 
median nerve in both hands. We performed BAEPs and VEPs on both sides and used 
the averages for statistical analyses. Because VEP assessment was not possible in one 
hospital (Okayama Kyoritsu Hospital), only the 23 participants at the other hospital 15 
were tested. Although pattern-reversal VEPs may be preferable because of their better 
specificity, we used flash VEPs due to its availability as routine procedure.   
 
2.5. Neuropsychological tests 
 One psychologist (TK) administered all of the neuropsychological tests to all 20 
participants. The tests took about half an hour on average, although exposed subjects 
generally took longer than the controls. 
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2.5.1. Two subtests (Vocabulary and Block Design) from Wechsler Adults Intelligent 
Scale III (WAIS-III) 
 WAIS-III is a test for measuring intelligence in adults and contains 14 subtests. 
Out of those, we selected two (Vocabulary and Block Design). With regard to 
Vocabulary, words of increasing difficulty were presented to the participants both orally 5 
and visually, and they were asked to define the words. This component measures verbal 
knowledge and concept formation. With regard to Block Design, the participants were 
asked to arrange the blocks to match the design formed by the examiner or shown on 
cards. This component measures spatial problem-solving and manipulative abilities. We 
then calculated standardized scores of both components. 10 
 
2.5.2. Design memory subtest from Wide Range Assessment of Memory and Learning 2 
(WRAML2) 
 WRAML2 measures learning and memory functions and is composed of six 
core subtests. We selected design memory subtest among them. The participants viewed 15 
each card for five seconds, and then after a ten-second delay the participants were asked 
to draw what they remembered. The participants repeated the task five times for five 
stimulus cards. The subtest measures reproduction from visual memory.  
 
2.5.3. Grooved pegboard test 20 
 Grooved pegboard is a dexterity test to measure complex visual-motor 
coordination. We used the Grooved Pegboard (Model 32025, Lafayette Instrument 
Company, USA), which consists of 25 holes with randomly positioned slots. The 
participants were asked to rotate pegs, which have a key along one side, to match the 
10 
 
hole. The participants performed the test with both dominant and non-dominant hands. 
We recorded the duration (in seconds) required to perform each trial, beginning when 
the participants started the task and ending when the last peg was correctly placed.  
 
2.5.4. Finger tapping test 5 
 Finger tapping measures maximum oscillation rate of the index finger, which 
can act as an indicator of psychomotor disruption. The participants were asked to tap the 
circular paddle attached to a counter as rapidly as possible in a ten-second trial period 
and the number of times the participants tapped was recorded. If five consecutive scores 
within a range of five points were obtained, we calculated the mean of those five scores 10 
for the final score. But, if not, we administered ten trials and calculated the mean of the 
five highest scores for the final score. We used Finger Tapper (Model 32726, Lafayette 
Instrument Company, USA). 
 
2.6. Statistical analyses 15 
 We compared descriptive characteristics between exposed and unexposed 
participants. We also compared neurological, neurophysiological, and 
neuropsychological outcomes between them. We used chi-square tests for binary 
outcomes and t-tests for continuous outcomes. To the extent that demographic 
characteristics significantly differed between exposed and unexposed participants, we 20 
performed multivariate analysis adjusting for the relevant parameters. However, we did 
not adjust for parameters considered to be intermediate variables between arsenic 
exposure and outcomes or possible outcomes of the exposure (e.g., education or 
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employment status). With regard to the Grooved pegboard and Finger tapping tests, we 
compared the outcomes for dominant and non-dominant hands. 
 As a sensitivity analysis, we repeated the analyses after exclusion of 12 
exposed participants who received regular health examinations offered by the Hikari 
Association (due to the severity of their disorders). We also repeated the analyses after 5 
excluding the participants who had been identified by the neurologists as having 
abnormal mental functions. In a sensitivity analysis, we also excluded participants with 
higher education, mainly from the control group, and repeated the analysis. We further 
compared outcomes between the exposed participants born in 1954 and those born in 
1955.  10 
 PASW Statistics software (SPSS Japan Inc., version 18.0J) was used for the 
analyses. We report two-sided p-values, and those  less than 0.05 were considered 
significant. 
 
2.7. Ethical issues 15 
 This study was approved by the Institutional Review Boards of Okayama 
University (No. 487) and at each hospital. All of the participants provided written 
informed consent. 
 
3. Results 20 
 Demographic characteristics by exposure status are shown in Table 1. While 
age or sex were not significantly different, the unexposed participants were more likely 
to have higher education or to be employed. 
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 Table 2 shows the summarized neurological findings. The exposed participants 
were more likely to have problems related with mental function, motor function, and 
autonomic function than the unexposed participants, but the difference was statistically 
significant only for mental function. The mental problems identified by the neurologists 
included schizophrenia (n=3), depression (n=1), and intellectual disability (n=2).  5 
 With regard to neurophysiological findings (NCVs, BAEPs, and VEPs), we did 
not observe any clear difference between the groups, although some latencies, 
especially in VEP, tended to be longer in the exposed group (Table 3). However, the 
exposed participants had more unfavorable neuropsychological outcomes than the 
unexposed participants (Table 4). All of the scores except for Finger Tapping were 10 
significantly lower or longer among the exposed than the unexposed. Most of the means 
and standard deviations (SDs) of the controls were close to expectation. Thus, scaled 
scores are based on a mean of 10 with a SD of 3 for the WAIS-III subtests [30] and 
Design memory [16], while expected values were 68.10 (9.42) for the dominant hand 
and 74.70 (10.51) for the non-dominant hand in the Grooved pegboard tests [9]. 15 
However, the exposed group showed averages that were at least 1.2 SDs below the 
average for the controls. Likewise, the SDs of the exposed group were much greater for 
all tests, except for Finger Tapping.  
 After excluding 12 exposed participants who received regular health 
examinations offered by the Hikari Association, no significant difference in mental 20 
status was observed and the neurophysiological findings were consistent with the 
original analysis (data not shown). However, the exposed participants still had 
significantly unfavorable outcomes on the two WAIS-III subtests and on Grooved 
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pegboard (Table 5). The means differed by at least 0.7 SD, and the variability within the 
exposed group remained high.  
 In addition, even after excluding six participants identified by the neurologists 
as having abnormal mental functions, the exposed participants still had unfavorable 
outcomes on the neuropsychological tests (Table 6). Again, the means of the two groups 5 
differed by at least 0.7 SD. 
 When we excluded participants with high educational attainment (i.e., 
university or higher) (n=3 for the exposed and n=9 for the unexposed), the exposed 
participants still had unfavorable outcomes on neuropsychological tests (Table 7) and 
the means of the two groups differed by at least 1.2 SD. 10 
 Finally, the exposed participants born in 1955 and 1954 did not differ in regard 
to outcomes including neuropsychological performance (data not shown). However, 
after excluding six participants identified by the Hikari Association to have abnormal 
mental functions, the exposed participants born in 1954 tended to have more 
unfavorable neuropsychological outcomes than those born in 1955, and the variability 15 
within the former group remained high (Table 8).  
 
4. Discussion 
 The Morinaga milk poisoning episode affected thousands of victims, most of 
whom were infants who received the arsenic contamination from bottle feeding. More 20 
than 100 died from acute poisoning, and neurological sequelae were observed in severe 
cases at adolescence. Very limited follow-up has been accomplished, although elevated 
mortality from nervous system disease, respiratory disease, circulatory disease, external 
causes, and cancer were reported among the victims [19,34]. The present study reports 
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for the first time the neuropsychological functioning of victims at adult age. While 
limited abnormalities were found on the neurophysiological tests, neuropsychological 
deficits were apparent and remained significant after exclusion of participants with 
known disabilities or abnormal mental function. 
 Although inorganic arsenic poisoning is known to cause peripheral neuropathy 5 
[10,31], we observed no abnormalities in nerve conduction velocity (NCV). This could 
be because we only assessed motor and not sensory NCV. However, a likely 
explanation is that arsenic exposure during early infancy may particularly target central 
nervous functions rather than peripheral nerves that are known to be particularly 
vulnerable in adults [31]. Indeed, increased tendon reflexes rather than peripheral 10 
neuropathy, and absence of abnormalities in electromyogram were reported among the 
infant victims in the early phase of the milk poisoning [5]. 
 The types of neuropsychological deficits observed are consistent with previous 
studies of young subjects [12,21,33]. The present study suggests that multiple brain 
functions are negatively affected by the exposure, and it therefore seems plausible that 15 
arsenic exposure during early infancy may cause multi-domain or perhaps diffuse 
dysfunctions, and that the deficits are permanent, as one might anticipate in regard to 
developmental neurotoxicity [2]. Thus, the brain’s sensitivity to arsenic may change 
during infancy and childhood, and exposures at later ages may target more specific 
functions, with exposures at adult age primarily affecting the peripheral nervous system. 20 
 When the poisonings happened, the professional opinion at the time suggested 
that the victims would completely recover once the clinical symptoms faded. The 
present study documents that deficits persist at advanced age; at least through the late 
fifties. This finding is in accordance with the current notion that developmental 
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neurotoxicity is likely to be permanent, as has been shown in regard to arsenic 
[17,21,23] as well as other neurotoxicants, such as alcohol, lead, and methylmercury 
[2,6,11,15].  
 The number of subjects examined is small because we only recruited victims 
living in Okayama Prefecture, but statistical significance was achieved in regard to 5 
several outcomes. Despite the small number of subjects, the study sample likely 
represents the patient population that could be reasonably identified in the local 
community (e.g., Okayama Prefecture). Apart from the Hikari Association’s register of 
victims in need of support, no general listing is available to identify victims today. Our 
approach to inviting Morinaga milk poisoning victims therefore represents a feasible 10 
and reproducible means of selecting subjects with severe arsenic exposure during 
infancy. Still, many victims were probably not known to the hospitals, especially milder 
cases. However, we nonetheless observed unfavorable neuropsychological outcomes 
among the exposed participants even after excluding the 12 subjects with severe 
disabilities. Further, the healthy control group was not ideal, as hospital staff may not 15 
represent the general background population, as reflected by the average WAIS-III 
scores. However, other outcome parameters (i.e., Design memory and Grooved 
pegboard tests) were close to expectation for healthy subjects, and the differences in 
neuropsychological performance would be difficult to ascribe only to higher educational 
achievement of the controls as shown in the sensitivity analysis excluding those with the 20 
highest level of education (Table 7). Due to the early-life exposure of the poisoning 
victims and its cognitive consequences, further adjustment for education would be 
inappropriate. 
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 We do not have information about the duration of breast-feeding of the 
participants. As bottle-feeding was heavily promoted at the time, some infants probably 
received bottled milk from early age, perhaps along with breast milk. It is therefore not 
possible to distinguish any protective effects of breast-feeding on neurocognitive 
functions [8] in regard to the adverse effects of the contaminated milk powder, although 5 
confounding from breast-feeding would clearly be insufficient to explain the deficits 
observed in the exposed subjects.  
 Other limitations include the lack of information on the total dose of arsenic 
among the exposed participants. Any dose calculation is virtually impossible, because 
the arsenic concentration differed by lot number [1]. With an estimated arsenic 10 
concentration in milk made from the milk powder at about 4-7 mg/L [1], the total dose 
would depend on the duration of the bottle-feeding period. Subjects born in 1954 may 
have incurred a larger dose compared to those born in 1955, as the contaminated milk 
powder was available for only 3-4 months during the summer of 1955, and 
bottle-feeding of the youngest subjects may have overlapped to a lesser degree with this 15 
period. A difference in dose rather than differences in vulnerability may therefore 
explain the slightly worse outcomes among those born in 1954 than those in 1955 
(Table 8).  
 Although all examiners were blinded as to the participants’ exposure status, the 
neurologists working for the hospitals may well have been aware of the exposure status 20 
of the participants. However, other tests would likely be more robust to this possible 
observer bias. 
 In conclusion, the present study indicates that adults who suffered arsenic 
poisoning during infancy reveal neuropsychological dysfunctions, while 
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neurophysiological testing failed to show clear abnormalities. Unfavorable 
neuropsychological outcomes were present in participants without known disabilities or 
abnormal mental function. These findings support the notion that developmental arsenic 
neurotoxicity is likely to result in permanent changes in brain functions. Relatively high 
exposures to arsenic still occur, e.g., through drinking water in West Bengal, India, and 5 
Bangladesh, where arsenic concentrations in water can reach 1-2mg/L [13,25], i.e., 
similar to the levels in prepared milk using the Morinaga milk powder. The present 
findings therefore support the notion that prevention of early-life exposures to such 
substances should be vigorously pursued.  
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